Edition:
India

Clovis Oncology Inc (CLVS.O)

CLVS.O on Nasdaq

14.44USD
20 Jun 2019
Change (% chg)

$-0.33 (-2.23%)
Prev Close
$14.77
Open
$14.70
Day's High
$14.98
Day's Low
$14.03
Volume
1,939,887
Avg. Vol
1,555,156
52-wk High
$50.00
52-wk Low
$11.50

About

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $782.88
Shares Outstanding(Mil.): 53.00
Dividend: --
Yield (%): --

Financials

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

13 Apr 2019

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

April 12 Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

13 Apr 2019

Earnings vs. Estimates